1. Home
  2. CHEK vs PRSO Comparison

CHEK vs PRSO Comparison

Compare CHEK & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • PRSO
  • Stock Information
  • Founded
  • CHEK 2004
  • PRSO 2008
  • Country
  • CHEK Israel
  • PRSO United States
  • Employees
  • CHEK N/A
  • PRSO N/A
  • Industry
  • CHEK Medical Electronics
  • PRSO Semiconductors
  • Sector
  • CHEK Health Care
  • PRSO Technology
  • Exchange
  • CHEK Nasdaq
  • PRSO Nasdaq
  • Market Cap
  • CHEK 4.3M
  • PRSO 4.3M
  • IPO Year
  • CHEK 2015
  • PRSO 2001
  • Fundamental
  • Price
  • CHEK $0.76
  • PRSO $1.00
  • Analyst Decision
  • CHEK
  • PRSO Strong Buy
  • Analyst Count
  • CHEK 0
  • PRSO 1
  • Target Price
  • CHEK N/A
  • PRSO $3.00
  • AVG Volume (30 Days)
  • CHEK 29.6K
  • PRSO 433.7K
  • Earning Date
  • CHEK 08-14-2025
  • PRSO 08-11-2025
  • Dividend Yield
  • CHEK N/A
  • PRSO N/A
  • EPS Growth
  • CHEK N/A
  • PRSO N/A
  • EPS
  • CHEK N/A
  • PRSO N/A
  • Revenue
  • CHEK N/A
  • PRSO $15,626,000.00
  • Revenue This Year
  • CHEK N/A
  • PRSO $3.96
  • Revenue Next Year
  • CHEK N/A
  • PRSO $36.80
  • P/E Ratio
  • CHEK N/A
  • PRSO N/A
  • Revenue Growth
  • CHEK N/A
  • PRSO 35.50
  • 52 Week Low
  • CHEK $0.56
  • PRSO $0.52
  • 52 Week High
  • CHEK $3.04
  • PRSO $2.34
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 45.42
  • PRSO 47.80
  • Support Level
  • CHEK $0.75
  • PRSO $1.05
  • Resistance Level
  • CHEK $0.86
  • PRSO $1.29
  • Average True Range (ATR)
  • CHEK 0.03
  • PRSO 0.13
  • MACD
  • CHEK 0.00
  • PRSO -0.02
  • Stochastic Oscillator
  • CHEK 33.11
  • PRSO 13.64

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: